BAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Braskem SA (BAK) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is deteriorating, analysts have lowered price targets, and there are no strong positive catalysts or trading signals. Holding off on investment is recommended.
The MACD is slightly positive but contracting, RSI is neutral at 48.973, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock price has dropped significantly (-13.26% in regular trading) and is trading near key support levels (S1: 3.426).
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The Brazilian President's veto of the proposed REIQ increase for 2026 negatively impacted the stock. Analysts have lowered price targets, and the company's financials show significant declines in revenue, net income, EPS, and gross margin.
In Q3 2025, revenue dropped by -17.18% YoY, net income fell by -95.54% YoY, EPS declined by -92.31% YoY, and gross margin decreased by -76.18% YoY. The company is facing severe financial challenges.
BofA has lowered the price target to $3.30 from $3.70 and maintains a Neutral rating. The recent veto on the REIQ increase for 2026 is seen as a negative development.
